State Leader Welcomes Orzax Group's Chairman at Official Meeting
Orzax Group to Establish Dietary Supplement Production Plant in Kazakhstan
Orzax Group, a global leader in dietary supplements, has announced plans to build a production plant in the Turkestan region of Kazakhstan. The ambitious project, set to cost $40 million, is expected to provide permanent employment for around 500 people and significantly boost the country's pharmaceutical industry and export potential.
The news was shared following a meeting between Kassym-Jomart Tokayev, President of Kazakhstan, and the company's management. During the meeting, held in Ankara, President Tokayev expressed his support for the initiative, highlighting its role in diversifying Kazakhstan's domestic pharmaceutical industry and enhancing its export potential.
Orzax Group's new facility will expand the company's production capacity locally and focus on scientific research and innovation. The company currently produces 150 types of dietary supplements and exports to 60 countries worldwide. This development is expected to strengthen Kazakhstan's position in the global dietary supplement market.
The plant's construction in the Turkestan region is a significant step for the country's pharmaceutical industry. The project is currently in the development phase, with Orzax Group intending to invest $40 million and create 500 permanent jobs.
President Tokayev emphasized that the initiative would contribute to the domestic pharmaceutical industry's diversification. This move is expected to enhance Kazakhstan's capabilities in domestic pharmaceutical manufacturing, providing a boost to the country's economy.
The discussions between Orzax Group and President Tokayev centred around the implementation of joint projects. With this new plant, Orzax Group plans to develop research and innovation directions in Kazakhstan, further cementing its commitment to the country and its people.
This news was reported by our website with reference to Akorda, marking an exciting development in Kazakhstan's pharmaceutical industry and its global standing in the dietary supplement market.
The Orzax Group, a global leader in dietary supplements, aims to diversify Kazakhstan's domestic pharmaceutical industry by investing $40 million in a production plant in the Turkestan region, creating 500 permanent jobs.
Orzax Group's new facility will focus on scientific research and innovation, expanding the company's production capacity locally and strengthening Kazakhstan's position in the global dietary supplement market.
This initiative, expected to boost the country's pharmaceutical industry and export potential, is aligned with Orzax Group's business strategy, which includes a strong commitment to health-and-wellness and nutrition.
President Tokayev's support for this project signifies a significant step in Kazakhstan's finance sector, as the country attracts investments in the real-estate, pharmaceutical, and dietary supplement industries, contributing to its economic growth and development.
